Our results showed lower IL-1β and IL-6 levels in the shKDELC2-transfected glioblastoma cells compared to the shLuc-transfected glioblastoma cells but demonstrated a marked increase in the above factors after the addition of recombinant OE-KDELC2 (Figure 5D). This evidence concerns the gene IL6 and glioblastoma.